WandstratTLKaplanB. Use of erythropoietin in premature neonates: Controversies and the future. Ann Pharmacother1995; 29: 166–73.
2.
ShekhawatPHoffmannRGSasidharanP. Meta-analysis of the randomized controlled trials (RCTs) of recombinant human erythropoietin (EPO) in anemia of prematurity (AOP) (abstract). Pediatr Res1996; 39: 291A.
3.
OhlsRKVeermanMWChristensenRD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. J Pediatr1996; 128: 518–23.
4.
ShannonKMKeithJFMentzerWCEhrenkranzRABrownMSWidnessJA. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics1995; 95: 1–8.